BrightEdge Fund logo

BrightEdge Fund

North America, Georgia, United States, Atlanta

Description

BrightEdge Fund is a cancer society’s donor-funded philanthropic impact fund.

Investor Profile

BrightEdge Fund has made 24 investments, with 1 in the past 12 months and 8% as lead.

Stage Focus

  • Series A (29%)
  • Seed (25%)
  • Series B (17%)
  • Series Unknown (13%)
  • Series D (8%)
  • Series C (8%)

Country Focus

  • United States (92%)
  • United Kingdom (4%)
  • Israel (4%)

Industry Focus

  • Biotechnology
  • Health Care
  • Therapeutics
  • Health Diagnostics
  • Medical
  • Personal Health
  • Wellness
  • Life Science
  • Fitness
  • Oncology
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does BrightEdge Fund frequently co-invest with?

Catalio Capital Management
North America, New York, United States, New York
Co-Investments: 3
Google Ventures
North America, California, United States, Mountain View
Co-Investments: 5
T. Rowe Price
North America, Maryland, United States, Baltimore
Co-Investments: 4
Bain Capital Life Sciences
North America, Massachusetts, United States, Boston
Co-Investments: 4
RA Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 5
Artis Ventures (AV)
North America, California, United States, San Francisco
Co-Investments: 3
Polaris Partners
North America, Massachusetts, United States, Boston
Co-Investments: 7
Perceptive Advisors
North America, New York, United States, New York
Co-Investments: 4
Andreessen Horowitz
North America, California, United States, Menlo Park
Co-Investments: 6
Section 32
North America, California, United States, San Diego
Co-Investments: 4

Which angels does BrightEdge Fund often collaborate with?

WS
North America, California, United States
Shared Deals: 1
MP
North America, California, United States
Shared Deals: 1
TF
North America, Texas, United States, Dallas
Shared Deals: 1
FB
North America, New York, United States, New York
Shared Deals: 3

What are some of recent deals done by BrightEdge Fund?

Auron Therapeutics

Newton, Massachusetts, United States

Auron aims to cure cancer therapeutics from cell killing to transformation of malignant cells into more normal functioning cells.

BiotechnologyHealth CareTherapeutics
Series BFeb 4, 2025
Amount Raised: $27,000,000
Clasp Therapeutics

Cambridge, Massachusetts, United States

Clasp Therapeutics offers to reach of immuno-oncology with novel precision medicines that enable the immune system.

BiotechnologyTherapeutics
Series AMar 20, 2024
Amount Raised: $150,000,000
Freenome

South San Francisco, California, United States

Freenome is a biotechnology company with a comprehensive multiomics platform for cancer detection using a routine blood draw.

BiotechnologyHealth CareHealth DiagnosticsPersonal Health
Series UnknownFeb 15, 2024
Amount Raised: $254,000,000
Modifi Bio

New Haven, Connecticut, United States

Modifi Biosciences is a leader in direct DNA modification and the development of novel cancer therapeutics.

BiotechnologyMedicalTherapeutics
SeedOct 16, 2023
Amount Raised: $4,300,000
Thatch

San Francisco, California, United States

Thatch helps startups give great healthcare to their teams.

Health Care
SeedFeb 15, 2023
Amount Raised: $5,600,000
Paradigm

New York, New York, United States

Paradigm creates a platform that allow all patients to participate in clinical trials while also enhancing trial efficiency.

Health CareHealth DiagnosticsHospitalLife Science
Series AJan 25, 2023
Amount Raised: $203,000,000
Alpheus Medical

Oakdale, Pennsylvania, United States

Alpheus Medical provides a novel sonodynamic therapy platform targeting solid body cancers.

BiotechnologyHealth CareHealth DiagnosticsMedical
Series ANov 10, 2022
Amount Raised: $14,000,000
Vincere Health

Stoneham, Massachusetts, United States

Vincere Health is a smarter incentives, biofeedback and coaching platform for behavior change.

FitnessHealth CareSoftwareWearablesWellness
SeedOct 5, 2022
Amount Raised: $1,750,000
Meliora Therapeutics

San Francisco, California, United States

Meliora Therapeutics is a biotech startup that is developing a machine learning-driven platform.

BiotechnologyTherapeutics
SeedSep 29, 2022
Amount Raised: $11,000,000
Naveris

Waltham, Massachusetts, United States

Naveris is a biotechnology company that provides clinically validated blood tests for the early detection of cancer.

BiotechnologyHealth CareMedical
Series ASep 19, 2022
Amount Raised: $33,400,000